Skip to main content
Not investment advice. Educational platform. See Disclaimer.
NASDAQ: LAB

Standard BioTools Inc.

Healthcare | Medical - Devices

No licensed closing price on file for LAB. This page shows the company’s SEC filings and filed figures, without a price or any ratio that depends on one.

EPS (TTM)$0.22

Standard BioTools Inc. (NASDAQ: LAB) is a medical device company. Figures from SEC EDGAR; updated 2026-10-20 23:42 UTC.

What Standard BioTools Inc. does

Standard BioTools is a life science tools company that provides instrumentation, consumables, and services for biomedical research across proteomics and genomics applications. The company operates several technology platforms, including CyTOF for single-cell analysis using mass cytometry, Hyperion for spatial biology imaging, and Biomark for high-throughput genomics and qPCR applications. In early 2026, the company sold its aptamer-based and functional proteomics business (SomaScan Business) to Illumina while retaining its mass cytometry and microfluidics businesses.

Summarized from Standard BioTools Inc.’s SEC filings · AI-generated analysis. Not investment advice. May contain errors. · Read the filing ↗

Key facts

Valuation
EPS (TTM)$0.22
Return on equity-17.65%

Revenue, margins & earnings

FY2021: net loss $59M on revenue $131M$131MFY2021FY2022: net loss $190M on revenue $98M$98MFY2022FY2023: net loss $75M on revenue $106M$106MFY2023FY2024: net loss $139M on revenue $91M$91MFY2024FY2025: net loss $75M on revenue $85M$85MFY2025
  • Net income
  • Taxes & interest
  • Operating costs
  • Net loss year
Annual revenue; bands show net, operating margins · Open in Platform →

SEC Filings

SEC EDGAR ↗
Recent Insider Activity (last 90 days)
Source: SEC EDGAR · Filed 2026-08-24
  • 2026-08-24SVP & Chief Business OfficerTax withholding-25,729$17.3K
  • 2026-08-24Chief Financial OfficerTax withholding-28,195$18.9K
  • 2026-08-24President & CEOTax withholding-97,627$65.6K
Sign in to see all transactions →
Recent 8-K Events (parsed from SEC filings)All events →
Source: SEC EDGAR 8-K filings · Interpretation: Oxford Ledge parser · Confidence-filtered ≥ 0.50

Company news

View all →

Questions this page answers

What does Standard BioTools Inc. do?

Standard BioTools is a life science tools company that provides instrumentation, consumables, and services for biomedical research across proteomics and genomics applications.

When did LAB last file with the SEC?

Standard BioTools Inc.'s most recent SEC filing on record is a 8-K filed 2026-06-18. All filings link to their SEC EDGAR originals above.

Where does this data come from?

SEC EDGAR filings, with the company profile (sector, industry, exchange) from public data providers, fetched 2026-10-20 23:42 UTC. This page is also available as JSON at /api/data?ticker=LAB and is emitted with FAQPage structured data for machine reading.

For you

Charts, 10-year financials, peer comparison, screening and portfolio tracking for LAB and 5,000+ tickers.

Create a free account — keep LAB
For your agent
GET /api/data?ticker=LAB

This page as JSON via rel="alternate" · REST API docs · MCP server (60 tools) · llms.txt